Literature DB >> 16845975

Drug adjuncts for treating alcohol dependence.

Gregory B Collins1, Mark S McAllister, Kamala Adury.   

Abstract

Three drugs are approved by the US Food and Drug Administration for treating alcoholism: disulfiram, naltrexone, and acamprosate. Drugs approved for other indications that are being used experimentally or "off-label" include nalmafene, topiramate, and ondansetron. As we learn more about the pathophysiologic basis of alcoholism, it is hoped that novel drugs can be developed to help people with alcohol dependence achieve abstinence, and as a result, curb alcohol-related morbidity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845975     DOI: 10.3949/ccjm.73.7.641

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  2 in total

1.  Effect of disulfiram on ketamine-induced cardiotoxicity in rats.

Authors:  Nihal Cetin; Bahadir Suleyman; Durdu Altuner; Ufuk Kuyrukluyildiz; Fatih Ozcicek; Resit Coskun; Nazahat Kurt; Halis Suleyman
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Safety and efficacy of acamprosate for the treatment of alcohol dependence.

Authors:  Stephanie L Yahn; Lucas R Watterson; M Foster Olive
Journal:  Subst Abuse       Date:  2013-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.